Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.33 Billion | -2.08 Billion | -2.51 Billion | -2.24 Billion | -3.41 Billion |
| Net Income | -1.48 Billion | -2.01 Billion | -2.61 Billion | -2.43 Billion | -3.06 Billion |
| Depreciation & Amortization | 87 Million | 58.97 Million | 59.23 Million | 45.38 Million | 45.94 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 29.76 Million | 75.61 Million | 70.9 Million | -8.23 Million |
| Change in working capital | 81 Million | -137.43 Million | -23.15 Million | 145.49 Million | -109.69 Million |
| Other non-cash items | -14 Million | -8.36 Million | 9.08 Million | -56.07 Million | -256.02 Million |
| Investing Cash Flow | -45 Million | 505.15 Million | 3.56 Billion | 340.39 Million | 4.59 Billion |
| Investments in PPE | -66 Million | -57.97 Million | -8.66 Million | -13.41 Million | - |
| Acquisitions | - | - | - | - | 8.24 Million |
| Investment purchases | - | -581.34 Million | -394.37 Million | -4.24 Billion | -5.12 Billion |
| Sales/Maturities of investments | - | 1.1 Billion | 3.81 Billion | 4.4 Billion | 9.39 Billion |
| Other Investing Activities | 21 Million | 25.19 Million | 134.76 Million | 119.55 Million | 94.41 Million |
| Financing Cash Flow | 96 Million | 1.44 Billion | 171.42 Million | 453.77 Million | 462.9 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 148.36 Million | 1.51 Billion | 319.89 Million | 597.2 Million | 661.7 Million |
| Other Financing Activities | 96 Million | - | - | 4.59 Million | - |
| Accounts receivables | 1 Million | -3.43 Million | - | - | - |
| Accounts payables | -11.65 Million | -40.76 Million | -1.75 Million | -19.75 Million | 75.39 Million |
| Inventory | - | - | - | - | - |
| Other working capital | 80 Million | -93.23 Million | -21.39 Million | 165.24 Million | -185.09 Million |
| Cash at beginning of period | 4.04 Billion | 3.97 Billion | 2.53 Billion | 4.19 Billion | 2.58 Billion |
| Cash at end of period | 2.76 Billion | 4.04 Billion | 3.97 Billion | 2.53 Billion | 4.19 Billion |
| Capital Expenditure | -66 Million | -57.97 Million | -8.66 Million | -13.41 Million | - |
| Effect of forex changes on cash | 3 Million | 206.4 Million | 223.1 Million | -204.05 Million | -30.69 Million |
| Net cash flow / Change in cash | -1.28 Billion | 71.65 Million | 1.44 Billion | -1.65 Billion | 1.6 Billion |
| Free Cash Flow | -1.4 Billion | -2.14 Billion | -2.52 Billion | -2.26 Billion | -3.41 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -326.19 Million | -342.74 Million | -1.48 Billion | -462.51 Million | -282.39 Million | -300.35 Million |
| Depreciation & Amortization | 17.11 Million | 14.61 Million | 87.16 Million | 23.49 Million | 22.06 Million | 22.72 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 6.79 Million | 8.74 Million | - | - | 9.96 Million | 8.44 Million |
| Change in working capital | -55.72 Million | -19.64 Million | -73.57 Million | 36.28 Million | -55.91 Million | -85.71 Million |
| Other non-cash items | 54.59 Million | -317 Thousand | 339.41 Million | 182.55 Million | -891 Thousand | -452 Thousand |
| Investing Cash Flow | -29.18 Million | 1.16 Million | -59.96 Million | -29.16 Million | -14.06 Million | -5.05 Million |
| Investments in PPE | -29.18 Million | -1.59 Million | -66.28 Million | -41.8 Million | -10.81 Million | -7.42 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3 Million | - | 6.32 Million | 12.64 Million | -6.32 Million | - |
| Financing Cash Flow | -15.56 Million | 4.42 Million | 96.58 Million | -14.33 Million | 25.12 Million | 35.4 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 19.05 Million | 148.36 Million | - | 35.59 Million | 50.17 Million |
| Other Financing Activities | -15.56 Million | - | - | - | - | - |
| Accounts receivables | 1.24 Million | 887 Thousand | 1.57 Million | 2 Million | -2.15 Million | 33 Thousand |
| Accounts payables | -14.51 Million | 4.04 Million | -11.65 Million | -18.26 Million | 12.15 Million | -11.74 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -42.45 Million | -24.57 Million | -63.49 Million | 52.54 Million | -65.91 Million | -73.99 Million |
| Cash at beginning of period | 2.45 Billion | 2.76 Billion | 4.04 Billion | 3.13 Billion | 3.41 Billion | 3.71 Billion |
| Cash at end of period | 2.06 Billion | 2.45 Billion | 2.76 Billion | 2.76 Billion | 3.13 Billion | 3.41 Billion |
| Capital Expenditure | -29.18 Million | -1.59 Million | -66.28 Million | -41.8 Million | -10.81 Million | -7.42 Million |
| Effect of forex changes on cash | 11.66 Million | 16.42 Million | - | - | 15.66 Million | 24.22 Million |
| Net cash flow / Change in cash | -390.76 Million | -313.81 Million | -1.28 Billion | -363.76 Million | -282.8 Million | -301.12 Million |
| Free Cash Flow | -386.86 Million | -337.42 Million | -1.38 Billion | -325.23 Million | -320.34 Million | -363.11 Million |
PNA1V
MAIRE
IIFLSEC
CRPG5
8065
2195